ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

June 28, 2002

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

Guy Newell, Anderson’s First Prevention Expert Past NCI Deputy, Dead

November 25, 1994